Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Menu
My View
  • Edit
  • Add your favourite topics for quick access
Meet the Team
Ask the Analyst
Partnered Content
PDF Library
RSS Feeds
Subscribe
Advertising
Report Store
UsernamePublicRestriction
Tags:

Phase I Trial Registration Required For Publication, Medical Journals Say

  • News

Executive Summary

Researchers will soon have to register their Phase I trial protocols, as well as Phase II and III data, in order to get their studies published in medical journals

You may also be interested in...



Trial Registry Bill Should Request Protocol With Results, FDA’s Temple Says

Any proposal to expand the ClinicalTrials.gov registry that does not require submission of trial protocols "does not do the whole job," FDA Office of Medical Policy Director Robert Temple said at a June 19 session of the Drug Information Association in Atlanta

Trial Registry Bill Should Request Protocol With Results, FDA’s Temple Says

Any proposal to expand the ClinicalTrials.gov registry that does not require submission of trial protocols "does not do the whole job," FDA Office of Medical Policy Director Robert Temple said at a June 19 session of the Drug Information Association in Atlanta

Chart: Waxman vs. Kennedy: A Side-By-Side Comparison of Drug Safety Bills From The House And Senate

Table

View full table

Tags:
UsernamePublicRestriction

Register

PS048455

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By